A Study to Determine the Safety and Efficacy of STI571 in Patients With Chronic Myeloid Leukemia Who Are Hematologically or Cytogenetically Resistant or Refractory to Interferon-Alpha, or Intolerant of, Interferon-Alpha

Name: A Study to Determine the Safety and Efficacy of STI571 in Patients With Chronic Myeloid Leukemia Who Are Hematologically or Cytogenetically Resistant or Refractory to Interferon-Alpha, or Intolerant of, Interferon-Alpha
Creator: Vivli
Published: 2025-12-16 15:13:06
License: 暂无描述

DataCite Commons2025-12-16 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00012204/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

RATIONALE: STI571 may interfere with the growth of cancer cells and may be effective treatment for chronic myelogenous leukemia.PURPOSE: Phase II trial to study the effectiveness of STI571 in treating patients who have chronic myeloid leukemia that has not responded to interferon alfa.

提供机构：

Vivli

创建时间：

2025-12-16